Article Details

Immunogenicity and safety of DS-5670d, an omicron XBB.1.5-targeting COVID-19 mRNA vaccine

Retrieved on: 2025-10-13 23:00:35

Tags for this article:

Click the tags to see associated articles and topics

Immunogenicity and safety of DS-5670d, an omicron XBB.1.5-targeting COVID-19 mRNA vaccine. View article details on hiswai:

Excerpt

A single dose of DS-5670d was immunogenically non-inferior to BNT162b2 and acceptably safe in persons with or without a history of prior infection ...

Article found on: pubmed.ncbi.nlm.nih.gov

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo